Cor Vasa 2024, 66(6):645-649 | DOI: 10.33678/cor.2024.083

(Antibiotic prophylaxis of infective endocarditis. Recommended practice guaranteed by the Czech Society of Infectious Diseases, the Czech Society for Medical Microbiology, and the Czech Professional Society of Clinical Pharmacy)

Jiří Beneša, Pavla Paterováb, Lukáš Bauerc, Václav Musild
a Klinika infekčních nemocí, 3. lékařská fakulta Univerzity Karlovy a Fakultní nemocnice Bulovka, Praha, Česká republika
b Ústav klinické mikrobiologie, Lékařská fakulta Univerzity Karlovy a Fakultní nemocnice Hradec Králové, Hradec Králové, Česká republika
c Oddělení klinické farmacie, Fakultní nemocnice Bulovka, Praha, Česká republika
d Klinika dětských infekčních nemocí, Lékařská fakulta Masarykovy univerzity a Fakultní nemocnice Brno, Brno, Česká republika

Keywords: antibiotic prophylaxis, dental surgery, infective endocarditis, national guidelines, Platnost od: 1. 10. 2024. Plánovaná revize: 1. 10. 2029.

Received: October 7, 2024; Accepted: October 13, 2024; Prepublished online: June 2, 2012; Published: December 20, 2024  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Beneš J, Paterová P, Bauer L, Musil V. (Antibiotic prophylaxis of infective endocarditis. Recommended practice guaranteed by the Czech Society of Infectious Diseases, the Czech Society for Medical Microbiology, and the Czech Professional Society of Clinical Pharmacy). Cor Vasa. 2024;66(6):645-649. doi: 10.33678/cor.2024.083.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Delgado V, Ajmone Marsan N, de Waha S, et al. 2023 ESC Guidelines for the management of endocarditis. Eur Heart J 2023;44:3948-4042. Go to original source... Go to PubMed...
    2. Línková H, Marek D, Mates M, et al. Doporučený postup Evropské kardiologické společnosti pro léčbu endokarditidy 2023. Delgado V, Ajmone Marsan N, de Waha S, et al. Překlad zkráceného dokumentu vypracovaný Pracovní skupinou pro chlopenní a vrozené srdeční vady České kardiologické společnosti, Českou společností kardiovaskulární chirurgie ČLS JEP a Společností infekčního lékařství ČLS JEP. Cor Vasa 2024;66:112-168.
    3. Beneš J. Kritický komentář k textu "2023 ESC Guidelines for the Management of Endocarditis". Cor Vasa 2024;66:455-465. Go to original source...
    4. Česká kardiologická společnost. Profylaxe infekční endokarditidy. Online. In: Kardio-cz.cz. Dostupné z: https://www.kardio-cz.cz/zakladni-informace-ps-chlopenni-a-vrozene-srdecni-vady-v-dospelosti-271/. [citováno 2024-11-06].
    5. Kaplan SL, Vallejo JG. Infective Endocarditis. In: Cherry JD, Harrison GJ, Kaplan SL, Steinbach WJ, Hotez PJ (eds.). Feigin and Cherry's Textbook of Pediatric Infectious Diseases, 8th ed. Elsevier, 2019:256-270.
    6. Holland TL, Bayer AS, Fowler VG Jr. Endocarditis and Endovascular Infections. In: Bennett JE, Dolin R, Blaser MJ (eds.). Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases, 9th ed. Elsevier, 2020:1068-1108.
    7. Little J. The American Heart Association's guidelines for the prevention of bacterial endocarditis: a critical review. Gen Dent 1998;46:508-515.
    8. Wilson W, Taubert KA, Gewitz M, et al. Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation 2007;116:1736-1754. Go to original source... Go to PubMed...
    9. Centre for Clinical Practice at NICE (UK). Prophylaxis Against Infective Endocarditis: Antimicrobial Prophylaxis Against Infective Endocarditis in Adults and Children Undergoing Interventional Procedures. London: National Institute for Health and Clinical Excellence (UK); 2008 Mar.
    10. Durack DT. Prevention of infective endocarditis. N Engl J Med 1995;332:38-44. Go to original source... Go to PubMed...
    11. Pelouch R. Profylaxe infekční endokarditidy. Interv Akut Kardiol 2011;10:170-174.
    12. Grayson ML (ed.). Kucers' the Use of Antibiotics, 6th ed. London: Edward Arnold Ltd., 2010. Go to original source...
    13. Chaudhry SB, Veve MP, Wagner JL. Cephalosporins: A Focus on Side Chains and β-Lactam Cross-Reactivity. Pharmacy (Basel) 2019;7:103. Go to original source... Go to PubMed...
    14. Maeda K, Hirai Y, Nashi M, et al. Clinical features and antimicrobial susceptibility of oral bacteria isolated from the blood cultures of patients with infective endocarditis. J Dent Sci 2022;17:870-875. Go to original source... Go to PubMed...
    15. Lafaurie GI, Noriega LA, Torres CC, et al. Impact of antibiotic prophylaxis on the incidence, nature, magnitude, and duration of bacteremia associated with dental procedures: A systematic review. J Am Dent Assoc 2019;150:948.e4-959.e4. Go to original source... Go to PubMed...
    16. Rouse MS, Steckelberg JM, Brandt CM, et al. Efficacy of azithromycin or clarithromycin for prophylaxis of viridans group streptococcus experimental endocarditis. Antimicrob Agents Chemother 1997;41:1673-1676. Go to original source... Go to PubMed...
    17. Glauser MP, Francioli P. Successful prophylaxis against experimental streptococcal endocarditis with bacteriostatic antibiotics. J Infect Dis 1982;146:806-810. Go to original source... Go to PubMed...
    18. Thornhill MH, Dayer MJ, Prendergast B, et al. Incidence and nature of adverse reactions to antibiotics used as endocarditis prophylaxis. J Antimicrob Chemother 2015;70:2382-2388. Go to original source... Go to PubMed...
    19. Cloitre A, Duval X, Tubiana S, et al. Antibiotic prophylaxis for the prevention of infective endocarditis for dental procedures is not associated with fatal adverse drug reactions in France. Med Oral Patol Oral Cir Bucal 2019;24:e296-e304. Go to original source... Go to PubMed...
    20. Hoen B, Duval X, Durack DT. Prevention of Infective Endocarditis. In: Bennett JE, Dolin R, Blaser MJ (eds.). Mandell's, Douglas, and Bennett's Principles and Practice of Infectious Diseases, 9th ed. Elsevier, 2020:1141-1150.
    21. Horstkotte D, Follath F, Gutschik E, et al. Guidelines on prevention, diagnosis and treatment of infective endocarditis executive summary; the Task Force on Infective Endocarditis of the European Society of Cardiology. Eur Heart J 2004;25:267-276. Go to original source... Go to PubMed...
    22. Habib G, Lancellotti P, Antunes MJ, et al. 2015 ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). Eur Heart J 2015;36:3075-3128. Go to original source... Go to PubMed...
    23. Hyun DY, Mason EO, Forbes A, Kaplan SL. Trimethoprim- -sulfamethoxazole or clindamycin for treatment of community- -acquired methicillin-resistant Staphylococcus aureus skin and soft tissue infections. Pediatr Infect Dis J 2009;28:57-59. Go to original source... Go to PubMed...
    24. McDougal LK, Fosheim GE, Nicholson A, et al. Emergence of resistance among USA300 methicillin-resistant Staphylococcus aureus isolates causing invasive disease in the United States. Antimicrob Agents Chemother 2010;54:3804-3811. Go to original source... Go to PubMed...
    25. Štefan M, Havránek J, Petrželová M, et al. Empirická ambulantní antibiotická terapie nejčastějších akutních komunitních bakteriálních infekcí u dětí. Pediatr praxi 2024;25:206-212. Go to original source...

    This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0), which permits non-comercial use, distribution, and reproduction in any medium, provided the original publication is properly cited. No use, distribution or reproduction is permitted which does not comply with these terms.


    Return to the content


    Cor et Vasa

    You are accessing a site intended for medical professionals, not the lay public. The site may also contain information that is intended only for persons authorized to prescribe and dispense medicinal products for human use.

    I therefore confirm that I am a healthcare professional under Act 40/1995 Coll. as amended by later regulations and that I have read the definition of a healthcare professional.


    No
    Yes